Adequate thromboprophylaxis in critically ill patients.docVIP

Levi Critical Care 2010,14:142 /content/14/2/142 COMMENTARY Adequate thromboprophylaxis in critically ill patients Marcel Levi* See related research by Robinson et al., /content/14/2/R41 limited bioavailability (that is, lower plasma anti-factor Abstract Xa activity) of subcutaneously administered heparin in Venous thromboembolism is a relatively frequently occurring complication in critically ill patients admitted to the ICU despite prophylactic treatment with subcutaneous low molecular weight heparin. Several studies show that critically ill patients have signi?cantly lower p